TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SPECTRONRX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

SPECTRONRX

ST13

US500000099140367

Class

40, 42

Filing

99140367

Registration

8141427

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

02/17/2026

Classification

Registered

Trademark type

Combined

Nice classes

40, 42

Filing date

04/16/2025

Registration date

02/17/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/17/2026

Last transaction

02/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

07/01/2020

First use in commerce

07/01/2020

Drawing code

5

Owner type

03

Owner location

Indianapolis, IN, US

Examiner

BECKER, MARY ELIZABETH

Law office

L30

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the wording "SPECTRONRX" in stylized font.

Holders and representatives

Holders

Nukemed, Inc.

Representatives

Steven D Murphy DeFur Voran LLP

Technical classification

Nice Classes

Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Engineering of pharmaceuticals, namely, custom manufacturing of pharmaceuticals

Class 42

Therapeutic and diagnostic development of pharmaceuticals, namely, pharmaceutical research and development

Publications

History of USPTO decisions and trademark events.

22 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/17/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/17/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/30/2025

PUBO

PUBLISHED FOR OPPOSITION

12/30/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/24/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/03/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/03/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/03/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

12/03/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

11/25/2025

GNFR

FINAL REFUSAL E-MAILED

11/25/2025

CNFR

FINAL REFUSAL WRITTEN

11/25/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/24/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/24/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/24/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/11/2025

GNRT

NON-FINAL ACTION E-MAILED

09/11/2025

CNRT

NON-FINAL ACTION WRITTEN

09/11/2025

DOCK

ASSIGNED TO EXAMINER

09/11/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/25/2025

MAFR

APPLICATION FILING RECEIPT MAILED

04/16/2025

NWAP

NEW APPLICATION ENTERED

04/16/2025

Continuous trademark protection

Get notified about every new filing that threatens SPECTRONRX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.